Cite
HARVARD Citation
Purroy, N. et al. (n.d.). Long‐term follow‐up of dose‐adjusted EPOCH plus rituximab (DA‐EPOCH‐R) in untreated patients with poor prognosis large B‐cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group. British journal of haematology. pp. 188-198. [Online].